<- Go Home
Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Market Cap
CNY 21.6B
Volume
13.2M
Cash and Equivalents
CNY 628.3M
EBITDA
CNY 1.8B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CNY 5.7B
Profit Margin
67.89%
52 Week High
CNY 17.69
52 Week Low
CNY 13.45
Dividend
2.15%
Price / Book Value
1.69
Price / Earnings
18.57
Price / Tangible Book Value
1.80
Enterprise Value
CNY 18.5B
Enterprise Value / EBITDA
N/A
Operating Income
CNY 1.5B
Return on Equity
8.73%
Return on Assets
6.11
Cash and Short Term Investments
N/A
Debt
CNY 1.1B
Equity
CNY 12.9B
Revenue
CNY 8.3B
Unlevered FCF
CNY 1.3B
Sector
Pharmaceuticals
Category
N/A